About Mybiotics
Mybiotics is a Healthcare company based in Ness Ziona (Israel) founded in 2014. Developing live biotherapeutic products using microbiome technologies for health. It operates on a B2B and D2C model. Mybiotics offers products and services including MBX-SD-201, MBX-SD-202, MBX-MC-101, and Supplements and Food. Its focus areas include Consumer Goods, Health Supplements, Nutraceuticals and Probiotic Products. Its legal entity is MyBiotics Pharma LTD.
Company details
MyBiotics is a clinical-stage company focused on creating live biotherapeutic products through innovative fermentation and formulation technologies. It addresses limitations in microbiome-based treatments by enhancing bacterial survival and engraftment. Based in Israel, the company collaborates with partners like Hadassah and Ferring for applications in oncology, gastroenterology, and womens health. Products target conditions such as Clostridium difficile infection and dysbiosis, bridging probiotics and pharmaceuticals.
- Headquarters Ness Ziona, Israel
- SectorsHealthcare
- Email••••••••
- Website mybiotix.com
- Social LinkedIn
- Legal Name Mybiotics Pharma Ltd
Products & Services of Mybiotics
Mybiotics offers a comprehensive portfolio of products and services, including MBX-SD-201, MBX-SD-202, MBX-MC-101, and Supplements and Food.
Treatment for acute Clostridium difficile infection
Whole microbiome treatment for restoration therapies
Product for acute dysbiosis management
Probiotic-based supplements for everyday health
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mybiotics
Complete news archive for Mybiotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mybiotics
Mybiotics was founded in 2014.
Mybiotics is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
MyBiotics is a clinical-stage company focused on creating live biotherapeutic products through innovative fermentation and formulation technologies. It addresses limitations in microbiome-based treatments by enhancing bacterial survival and engraftment. Based in Israel, the company collaborates with partners like Hadassah and Ferring for applications in oncology, gastroenterology, and womens health. Products target conditions such as Clostridium difficile infection and dysbiosis, bridging probiotics and pharmaceuticals.
Mybiotics offers MBX-SD-201, MBX-SD-202, MBX-MC-101, and Supplements and Food.
Mybiotics operates through Mybiotics Pharma Ltd.